Aerosol Delivery Devices Comprehensive Study by Type (Small-Volume Nebulize, Pressurized Metered-Dose Inhaler, Dry-Powder Inhaler), Application (Asthma, Chronic Obstructive Pulmonary Disease (COPD), Cystic Fibrosis, Non-Respiratory Diseases), Distribution Channel (Retail Pharmacies, Hospital Pharmacies, E-commerce), Nebulizer (Pneumatic Compressor Nebulizer, Ultrasonic Nebulizer, Vibrating Mesh/Horn Nebulizer, Microprocessor-Controlled Breath-Actuated Nebulizer) Players and Region - Global Market Outlook to 2026

Report Objectives / Segmentation Covered

• Small-Volume Nebulize
• Pressurized Metered-Dose Inhaler
• Dry-Powder Inhaler

• Asthma
• Chronic Obstructive Pulmonary Disease (COPD)
• Cystic Fibrosis
• Non-Respiratory Diseases

• Retail Pharmacies
• Hospital Pharmacies
• E-commerce

• Pneumatic Compressor Nebulizer
• Ultrasonic Nebulizer
• Vibrating Mesh/Horn Nebulizer
• Microprocessor-Controlled Breath-Actuated Nebulizer

• South America
  • Brazil
  • Argentina
  • Rest of South America
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Taiwan
  • Australia
  • Rest of Asia-Pacific
• Europe
  • Germany
  • France
  • Italy
  • United Kingdom
  • Netherlands
  • Rest of Europe
• MEA
  • Middle East
  • Africa
• North America
  • United States
  • Canada
  • Mexico

• 1. Market Overview
  • 1.1. Introduction
  • 1.2. Scope/Objective of the Study
    • 1.2.1. Research Objective
• 2. Executive Summary
  • 2.1. Introduction
• 3. Market Dynamics
  • 3.1. Introduction
  • 3.2. Market Drivers
    • 3.2.1. Increase in Demand for Home Healthcare Devices
    • 3.2.2. Development in the Healthcare Industry
    • 3.2.3. Increase in Government Budgets in Healthcare Infrastructure
  • 3.3. Market Challenges
    • 3.3.1. The Slowdown in Economy, Because of Coronavirus Pandemic
  • 3.4. Market Trends
    • 3.4.1. Increase Investment in the Research and Development
    • 3.4.2. Increase in Healthcare Reforms
    • 3.4.3. Continuous Investment in Technological Advancements in Aerosol Delivery Devices
• 4. Market Factor Analysis
  • 4.1. Porters Five Forces
  • 4.2. Supply/Value Chain
  • 4.3. PESTEL analysis
  • 4.4. Market Entropy
  • 4.5. Patent/Trademark Analysis
• 5. Global Aerosol Delivery Devices, by Type, Application, Distribution Channel, Nebulizer and Region (value, volume and price ) (2015-2020)
  • 5.1. Introduction
  • 5.2. Global Aerosol Delivery Devices (Value)
    • 5.2.1. Global Aerosol Delivery Devices by: Type (Value)
      • 5.2.1.1. Small-Volume Nebulize
      • 5.2.1.2. Pressurized Metered-Dose Inhaler
      • 5.2.1.3. Dry-Powder Inhaler
    • 5.2.2. Global Aerosol Delivery Devices by: Application (Value)
      • 5.2.2.1. Asthma
      • 5.2.2.2. Chronic Obstructive Pulmonary Disease (COPD)
      • 5.2.2.3. Cystic Fibrosis
      • 5.2.2.4. Non-Respiratory Diseases
    • 5.2.3. Global Aerosol Delivery Devices by: Distribution Channel (Value)
      • 5.2.3.1. Retail Pharmacies
      • 5.2.3.2. Hospital Pharmacies
      • 5.2.3.3. E-commerce
    • 5.2.4. Global Aerosol Delivery Devices by: Nebulizer (Value)
      • 5.2.4.1. Pneumatic Compressor Nebulizer
      • 5.2.4.2. Ultrasonic Nebulizer
      • 5.2.4.3. Vibrating Mesh/Horn Nebulizer
      • 5.2.4.4. Microprocessor-Controlled Breath-Actuated Nebulizer
    • 5.2.5. Global Aerosol Delivery Devices Region
      • 5.2.5.1. South America
        • 5.2.5.1.1. Brazil
        • 5.2.5.1.2. Argentina
        • 5.2.5.1.3. Rest of South America
      • 5.2.5.2. Asia Pacific
        • 5.2.5.2.1. China
        • 5.2.5.2.2. Japan
        • 5.2.5.2.3. India
        • 5.2.5.2.4. South Korea
        • 5.2.5.2.5. Taiwan
        • 5.2.5.2.6. Australia
        • 5.2.5.2.7. Rest of Asia-Pacific
      • 5.2.5.3. Europe
        • 5.2.5.3.1. Germany
        • 5.2.5.3.2. France
        • 5.2.5.3.3. Italy
        • 5.2.5.3.4. United Kingdom
        • 5.2.5.3.5. Netherlands
        • 5.2.5.3.6. Rest of Europe
      • 5.2.5.4. MEA
        • 5.2.5.4.1. Middle East
        • 5.2.5.4.2. Africa
      • 5.2.5.5. North America
        • 5.2.5.5.1. United States
        • 5.2.5.5.2. Canada
        • 5.2.5.5.3. Mexico
  • 5.3. Global Aerosol Delivery Devices (Volume)
    • 5.3.1. Global Aerosol Delivery Devices by: Type (Volume)
      • 5.3.1.1. Small-Volume Nebulize
      • 5.3.1.2. Pressurized Metered-Dose Inhaler
      • 5.3.1.3. Dry-Powder Inhaler
    • 5.3.2. Global Aerosol Delivery Devices by: Application (Volume)
      • 5.3.2.1. Asthma
      • 5.3.2.2. Chronic Obstructive Pulmonary Disease (COPD)
      • 5.3.2.3. Cystic Fibrosis
      • 5.3.2.4. Non-Respiratory Diseases
    • 5.3.3. Global Aerosol Delivery Devices by: Distribution Channel (Volume)
      • 5.3.3.1. Retail Pharmacies
      • 5.3.3.2. Hospital Pharmacies
      • 5.3.3.3. E-commerce
    • 5.3.4. Global Aerosol Delivery Devices by: Nebulizer (Volume)
      • 5.3.4.1. Pneumatic Compressor Nebulizer
      • 5.3.4.2. Ultrasonic Nebulizer
      • 5.3.4.3. Vibrating Mesh/Horn Nebulizer
      • 5.3.4.4. Microprocessor-Controlled Breath-Actuated Nebulizer
    • 5.3.5. Global Aerosol Delivery Devices Region
      • 5.3.5.1. South America
        • 5.3.5.1.1. Brazil
        • 5.3.5.1.2. Argentina
        • 5.3.5.1.3. Rest of South America
      • 5.3.5.2. Asia Pacific
        • 5.3.5.2.1. China
        • 5.3.5.2.2. Japan
        • 5.3.5.2.3. India
        • 5.3.5.2.4. South Korea
        • 5.3.5.2.5. Taiwan
        • 5.3.5.2.6. Australia
        • 5.3.5.2.7. Rest of Asia-Pacific
      • 5.3.5.3. Europe
        • 5.3.5.3.1. Germany
        • 5.3.5.3.2. France
        • 5.3.5.3.3. Italy
        • 5.3.5.3.4. United Kingdom
        • 5.3.5.3.5. Netherlands
        • 5.3.5.3.6. Rest of Europe
      • 5.3.5.4. MEA
        • 5.3.5.4.1. Middle East
        • 5.3.5.4.2. Africa
      • 5.3.5.5. North America
        • 5.3.5.5.1. United States
        • 5.3.5.5.2. Canada
        • 5.3.5.5.3. Mexico
  • 5.4. Global Aerosol Delivery Devices (Price)
    • 5.4.1. Global Aerosol Delivery Devices by: Type (Price)
• 6. Aerosol Delivery Devices: Manufacturers/Players Analysis
  • 6.1. Competitive Landscape
    • 6.1.1. Market Share Analysis
      • 6.1.1.1. Top 3
      • 6.1.1.2. Top 5
  • 6.2. Peer Group Analysis (2020)
  • 6.3. BCG Matrix
  • 6.4. Company Profile
    • 6.4.1. 3M Company (United States)
      • 6.4.1.1. Business Overview
      • 6.4.1.2. Products/Services Offerings
      • 6.4.1.3. Financial Analysis
      • 6.4.1.4. SWOT Analysis
    • 6.4.2. Aerogen, Inc. (Ireland)
      • 6.4.2.1. Business Overview
      • 6.4.2.2. Products/Services Offerings
      • 6.4.2.3. Financial Analysis
      • 6.4.2.4. SWOT Analysis
    • 6.4.3. Glaxosmithkline Plc (GSK) (United Kingdom)
      • 6.4.3.1. Business Overview
      • 6.4.3.2. Products/Services Offerings
      • 6.4.3.3. Financial Analysis
      • 6.4.3.4. SWOT Analysis
    • 6.4.4. Johnson & Johnson (Actelion Pharmaceuticals Ltd) (United States)
      • 6.4.4.1. Business Overview
      • 6.4.4.2. Products/Services Offerings
      • 6.4.4.3. Financial Analysis
      • 6.4.4.4. SWOT Analysis
    • 6.4.5. Philips (Koninklijke Philips N.V.) (Netherlands)
      • 6.4.5.1. Business Overview
      • 6.4.5.2. Products/Services Offerings
      • 6.4.5.3. Financial Analysis
      • 6.4.5.4. SWOT Analysis
    • 6.4.6. Merck & Co., Inc. (United States)
      • 6.4.6.1. Business Overview
      • 6.4.6.2. Products/Services Offerings
      • 6.4.6.3. Financial Analysis
      • 6.4.6.4. SWOT Analysis
    • 6.4.7. Metall Zug Group (Clement Clarke International Ltd) (Switzerland)
      • 6.4.7.1. Business Overview
      • 6.4.7.2. Products/Services Offerings
      • 6.4.7.3. Financial Analysis
      • 6.4.7.4. SWOT Analysis
    • 6.4.8. Recipharm AB (Bespak) (Sweden)
      • 6.4.8.1. Business Overview
      • 6.4.8.2. Products/Services Offerings
      • 6.4.8.3. Financial Analysis
      • 6.4.8.4. SWOT Analysis
    • 6.4.9. Teva Pharmaceutical Industries Limited (Israel)
      • 6.4.9.1. Business Overview
      • 6.4.9.2. Products/Services Offerings
      • 6.4.9.3. Financial Analysis
      • 6.4.9.4. SWOT Analysis
    • 6.4.10. Vectura Group PLC (United Kingdom)
      • 6.4.10.1. Business Overview
      • 6.4.10.2. Products/Services Offerings
      • 6.4.10.3. Financial Analysis
      • 6.4.10.4. SWOT Analysis
• 7. Global Aerosol Delivery Devices Sale, by Type, Application, Distribution Channel, Nebulizer and Region (value, volume and price ) (2021-2026)
  • 7.1. Introduction
  • 7.2. Global Aerosol Delivery Devices (Value)
    • 7.2.1. Global Aerosol Delivery Devices by: Type (Value)
      • 7.2.1.1. Small-Volume Nebulize
      • 7.2.1.2. Pressurized Metered-Dose Inhaler
      • 7.2.1.3. Dry-Powder Inhaler
    • 7.2.2. Global Aerosol Delivery Devices by: Application (Value)
      • 7.2.2.1. Asthma
      • 7.2.2.2. Chronic Obstructive Pulmonary Disease (COPD)
      • 7.2.2.3. Cystic Fibrosis
      • 7.2.2.4. Non-Respiratory Diseases
    • 7.2.3. Global Aerosol Delivery Devices by: Distribution Channel (Value)
      • 7.2.3.1. Retail Pharmacies
      • 7.2.3.2. Hospital Pharmacies
      • 7.2.3.3. E-commerce
    • 7.2.4. Global Aerosol Delivery Devices by: Nebulizer (Value)
      • 7.2.4.1. Pneumatic Compressor Nebulizer
      • 7.2.4.2. Ultrasonic Nebulizer
      • 7.2.4.3. Vibrating Mesh/Horn Nebulizer
      • 7.2.4.4. Microprocessor-Controlled Breath-Actuated Nebulizer
    • 7.2.5. Global Aerosol Delivery Devices Region
      • 7.2.5.1. South America
        • 7.2.5.1.1. Brazil
        • 7.2.5.1.2. Argentina
        • 7.2.5.1.3. Rest of South America
      • 7.2.5.2. Asia Pacific
        • 7.2.5.2.1. China
        • 7.2.5.2.2. Japan
        • 7.2.5.2.3. India
        • 7.2.5.2.4. South Korea
        • 7.2.5.2.5. Taiwan
        • 7.2.5.2.6. Australia
        • 7.2.5.2.7. Rest of Asia-Pacific
      • 7.2.5.3. Europe
        • 7.2.5.3.1. Germany
        • 7.2.5.3.2. France
        • 7.2.5.3.3. Italy
        • 7.2.5.3.4. United Kingdom
        • 7.2.5.3.5. Netherlands
        • 7.2.5.3.6. Rest of Europe
      • 7.2.5.4. MEA
        • 7.2.5.4.1. Middle East
        • 7.2.5.4.2. Africa
      • 7.2.5.5. North America
        • 7.2.5.5.1. United States
        • 7.2.5.5.2. Canada
        • 7.2.5.5.3. Mexico
  • 7.3. Global Aerosol Delivery Devices (Volume)
    • 7.3.1. Global Aerosol Delivery Devices by: Type (Volume)
      • 7.3.1.1. Small-Volume Nebulize
      • 7.3.1.2. Pressurized Metered-Dose Inhaler
      • 7.3.1.3. Dry-Powder Inhaler
    • 7.3.2. Global Aerosol Delivery Devices by: Application (Volume)
      • 7.3.2.1. Asthma
      • 7.3.2.2. Chronic Obstructive Pulmonary Disease (COPD)
      • 7.3.2.3. Cystic Fibrosis
      • 7.3.2.4. Non-Respiratory Diseases
    • 7.3.3. Global Aerosol Delivery Devices by: Distribution Channel (Volume)
      • 7.3.3.1. Retail Pharmacies
      • 7.3.3.2. Hospital Pharmacies
      • 7.3.3.3. E-commerce
    • 7.3.4. Global Aerosol Delivery Devices by: Nebulizer (Volume)
      • 7.3.4.1. Pneumatic Compressor Nebulizer
      • 7.3.4.2. Ultrasonic Nebulizer
      • 7.3.4.3. Vibrating Mesh/Horn Nebulizer
      • 7.3.4.4. Microprocessor-Controlled Breath-Actuated Nebulizer
    • 7.3.5. Global Aerosol Delivery Devices Region
      • 7.3.5.1. South America
        • 7.3.5.1.1. Brazil
        • 7.3.5.1.2. Argentina
        • 7.3.5.1.3. Rest of South America
      • 7.3.5.2. Asia Pacific
        • 7.3.5.2.1. China
        • 7.3.5.2.2. Japan
        • 7.3.5.2.3. India
        • 7.3.5.2.4. South Korea
        • 7.3.5.2.5. Taiwan
        • 7.3.5.2.6. Australia
        • 7.3.5.2.7. Rest of Asia-Pacific
      • 7.3.5.3. Europe
        • 7.3.5.3.1. Germany
        • 7.3.5.3.2. France
        • 7.3.5.3.3. Italy
        • 7.3.5.3.4. United Kingdom
        • 7.3.5.3.5. Netherlands
        • 7.3.5.3.6. Rest of Europe
      • 7.3.5.4. MEA
        • 7.3.5.4.1. Middle East
        • 7.3.5.4.2. Africa
      • 7.3.5.5. North America
        • 7.3.5.5.1. United States
        • 7.3.5.5.2. Canada
        • 7.3.5.5.3. Mexico
  • 7.4. Global Aerosol Delivery Devices (Price)
    • 7.4.1. Global Aerosol Delivery Devices by: Type (Price)
• 8. Appendix
  • 8.1. Acronyms
• 9. Methodology and Data Source
  • 9.1. Methodology/Research Approach
    • 9.1.1. Research Programs/Design
    • 9.1.2. Market Size Estimation
    • 9.1.3. Market Breakdown and Data Triangulation
  • 9.2. Data Source
    • 9.2.1. Secondary Sources
    • 9.2.2. Primary Sources
  • 9.3. Disclaimer

• Table 1. Aerosol Delivery Devices: by Type(USD Million)
• Table 2. Aerosol Delivery Devices Small-Volume Nebulize , by Region USD Million (2015-2020)
• Table 3. Aerosol Delivery Devices Pressurized Metered-Dose Inhaler , by Region USD Million (2015-2020)
• Table 4. Aerosol Delivery Devices Dry-Powder Inhaler , by Region USD Million (2015-2020)
• Table 5. Aerosol Delivery Devices: by Application(USD Million)
• Table 6. Aerosol Delivery Devices Asthma , by Region USD Million (2015-2020)
• Table 7. Aerosol Delivery Devices Chronic Obstructive Pulmonary Disease (COPD) , by Region USD Million (2015-2020)
• Table 8. Aerosol Delivery Devices Cystic Fibrosis , by Region USD Million (2015-2020)
• Table 9. Aerosol Delivery Devices Non-Respiratory Diseases , by Region USD Million (2015-2020)
• Table 10. Aerosol Delivery Devices: by Distribution Channel(USD Million)
• Table 11. Aerosol Delivery Devices Retail Pharmacies , by Region USD Million (2015-2020)
• Table 12. Aerosol Delivery Devices Hospital Pharmacies , by Region USD Million (2015-2020)
• Table 13. Aerosol Delivery Devices E-commerce , by Region USD Million (2015-2020)
• Table 14. Aerosol Delivery Devices: by Nebulizer(USD Million)
• Table 15. Aerosol Delivery Devices Pneumatic Compressor Nebulizer , by Region USD Million (2015-2020)
• Table 16. Aerosol Delivery Devices Ultrasonic Nebulizer , by Region USD Million (2015-2020)
• Table 17. Aerosol Delivery Devices Vibrating Mesh/Horn Nebulizer , by Region USD Million (2015-2020)
• Table 18. Aerosol Delivery Devices Microprocessor-Controlled Breath-Actuated Nebulizer , by Region USD Million (2015-2020)
• Table 19. South America Aerosol Delivery Devices, by Country USD Million (2015-2020)
• Table 20. South America Aerosol Delivery Devices, by Type USD Million (2015-2020)
• Table 21. South America Aerosol Delivery Devices, by Application USD Million (2015-2020)
• Table 22. South America Aerosol Delivery Devices, by Distribution Channel USD Million (2015-2020)
• Table 23. South America Aerosol Delivery Devices, by Nebulizer USD Million (2015-2020)
• Table 24. Brazil Aerosol Delivery Devices, by Type USD Million (2015-2020)
• Table 25. Brazil Aerosol Delivery Devices, by Application USD Million (2015-2020)
• Table 26. Brazil Aerosol Delivery Devices, by Distribution Channel USD Million (2015-2020)
• Table 27. Brazil Aerosol Delivery Devices, by Nebulizer USD Million (2015-2020)
• Table 28. Argentina Aerosol Delivery Devices, by Type USD Million (2015-2020)
• Table 29. Argentina Aerosol Delivery Devices, by Application USD Million (2015-2020)
• Table 30. Argentina Aerosol Delivery Devices, by Distribution Channel USD Million (2015-2020)
• Table 31. Argentina Aerosol Delivery Devices, by Nebulizer USD Million (2015-2020)
• Table 32. Rest of South America Aerosol Delivery Devices, by Type USD Million (2015-2020)
• Table 33. Rest of South America Aerosol Delivery Devices, by Application USD Million (2015-2020)
• Table 34. Rest of South America Aerosol Delivery Devices, by Distribution Channel USD Million (2015-2020)
• Table 35. Rest of South America Aerosol Delivery Devices, by Nebulizer USD Million (2015-2020)
• Table 36. Asia Pacific Aerosol Delivery Devices, by Country USD Million (2015-2020)
• Table 37. Asia Pacific Aerosol Delivery Devices, by Type USD Million (2015-2020)
• Table 38. Asia Pacific Aerosol Delivery Devices, by Application USD Million (2015-2020)
• Table 39. Asia Pacific Aerosol Delivery Devices, by Distribution Channel USD Million (2015-2020)
• Table 40. Asia Pacific Aerosol Delivery Devices, by Nebulizer USD Million (2015-2020)
• Table 41. China Aerosol Delivery Devices, by Type USD Million (2015-2020)
• Table 42. China Aerosol Delivery Devices, by Application USD Million (2015-2020)
• Table 43. China Aerosol Delivery Devices, by Distribution Channel USD Million (2015-2020)
• Table 44. China Aerosol Delivery Devices, by Nebulizer USD Million (2015-2020)
• Table 45. Japan Aerosol Delivery Devices, by Type USD Million (2015-2020)
• Table 46. Japan Aerosol Delivery Devices, by Application USD Million (2015-2020)
• Table 47. Japan Aerosol Delivery Devices, by Distribution Channel USD Million (2015-2020)
• Table 48. Japan Aerosol Delivery Devices, by Nebulizer USD Million (2015-2020)
• Table 49. India Aerosol Delivery Devices, by Type USD Million (2015-2020)
• Table 50. India Aerosol Delivery Devices, by Application USD Million (2015-2020)
• Table 51. India Aerosol Delivery Devices, by Distribution Channel USD Million (2015-2020)
• Table 52. India Aerosol Delivery Devices, by Nebulizer USD Million (2015-2020)
• Table 53. South Korea Aerosol Delivery Devices, by Type USD Million (2015-2020)
• Table 54. South Korea Aerosol Delivery Devices, by Application USD Million (2015-2020)
• Table 55. South Korea Aerosol Delivery Devices, by Distribution Channel USD Million (2015-2020)
• Table 56. South Korea Aerosol Delivery Devices, by Nebulizer USD Million (2015-2020)
• Table 57. Taiwan Aerosol Delivery Devices, by Type USD Million (2015-2020)
• Table 58. Taiwan Aerosol Delivery Devices, by Application USD Million (2015-2020)
• Table 59. Taiwan Aerosol Delivery Devices, by Distribution Channel USD Million (2015-2020)
• Table 60. Taiwan Aerosol Delivery Devices, by Nebulizer USD Million (2015-2020)
• Table 61. Australia Aerosol Delivery Devices, by Type USD Million (2015-2020)
• Table 62. Australia Aerosol Delivery Devices, by Application USD Million (2015-2020)
• Table 63. Australia Aerosol Delivery Devices, by Distribution Channel USD Million (2015-2020)
• Table 64. Australia Aerosol Delivery Devices, by Nebulizer USD Million (2015-2020)
• Table 65. Rest of Asia-Pacific Aerosol Delivery Devices, by Type USD Million (2015-2020)
• Table 66. Rest of Asia-Pacific Aerosol Delivery Devices, by Application USD Million (2015-2020)
• Table 67. Rest of Asia-Pacific Aerosol Delivery Devices, by Distribution Channel USD Million (2015-2020)
• Table 68. Rest of Asia-Pacific Aerosol Delivery Devices, by Nebulizer USD Million (2015-2020)
• Table 69. Europe Aerosol Delivery Devices, by Country USD Million (2015-2020)
• Table 70. Europe Aerosol Delivery Devices, by Type USD Million (2015-2020)
• Table 71. Europe Aerosol Delivery Devices, by Application USD Million (2015-2020)
• Table 72. Europe Aerosol Delivery Devices, by Distribution Channel USD Million (2015-2020)
• Table 73. Europe Aerosol Delivery Devices, by Nebulizer USD Million (2015-2020)
• Table 74. Germany Aerosol Delivery Devices, by Type USD Million (2015-2020)
• Table 75. Germany Aerosol Delivery Devices, by Application USD Million (2015-2020)
• Table 76. Germany Aerosol Delivery Devices, by Distribution Channel USD Million (2015-2020)
• Table 77. Germany Aerosol Delivery Devices, by Nebulizer USD Million (2015-2020)
• Table 78. France Aerosol Delivery Devices, by Type USD Million (2015-2020)
• Table 79. France Aerosol Delivery Devices, by Application USD Million (2015-2020)
• Table 80. France Aerosol Delivery Devices, by Distribution Channel USD Million (2015-2020)
• Table 81. France Aerosol Delivery Devices, by Nebulizer USD Million (2015-2020)
• Table 82. Italy Aerosol Delivery Devices, by Type USD Million (2015-2020)
• Table 83. Italy Aerosol Delivery Devices, by Application USD Million (2015-2020)
• Table 84. Italy Aerosol Delivery Devices, by Distribution Channel USD Million (2015-2020)
• Table 85. Italy Aerosol Delivery Devices, by Nebulizer USD Million (2015-2020)
• Table 86. United Kingdom Aerosol Delivery Devices, by Type USD Million (2015-2020)
• Table 87. United Kingdom Aerosol Delivery Devices, by Application USD Million (2015-2020)
• Table 88. United Kingdom Aerosol Delivery Devices, by Distribution Channel USD Million (2015-2020)
• Table 89. United Kingdom Aerosol Delivery Devices, by Nebulizer USD Million (2015-2020)
• Table 90. Netherlands Aerosol Delivery Devices, by Type USD Million (2015-2020)
• Table 91. Netherlands Aerosol Delivery Devices, by Application USD Million (2015-2020)
• Table 92. Netherlands Aerosol Delivery Devices, by Distribution Channel USD Million (2015-2020)
• Table 93. Netherlands Aerosol Delivery Devices, by Nebulizer USD Million (2015-2020)
• Table 94. Rest of Europe Aerosol Delivery Devices, by Type USD Million (2015-2020)
• Table 95. Rest of Europe Aerosol Delivery Devices, by Application USD Million (2015-2020)
• Table 96. Rest of Europe Aerosol Delivery Devices, by Distribution Channel USD Million (2015-2020)
• Table 97. Rest of Europe Aerosol Delivery Devices, by Nebulizer USD Million (2015-2020)
• Table 98. MEA Aerosol Delivery Devices, by Country USD Million (2015-2020)
• Table 99. MEA Aerosol Delivery Devices, by Type USD Million (2015-2020)
• Table 100. MEA Aerosol Delivery Devices, by Application USD Million (2015-2020)
• Table 101. MEA Aerosol Delivery Devices, by Distribution Channel USD Million (2015-2020)
• Table 102. MEA Aerosol Delivery Devices, by Nebulizer USD Million (2015-2020)
• Table 103. Middle East Aerosol Delivery Devices, by Type USD Million (2015-2020)
• Table 104. Middle East Aerosol Delivery Devices, by Application USD Million (2015-2020)
• Table 105. Middle East Aerosol Delivery Devices, by Distribution Channel USD Million (2015-2020)
• Table 106. Middle East Aerosol Delivery Devices, by Nebulizer USD Million (2015-2020)
• Table 107. Africa Aerosol Delivery Devices, by Type USD Million (2015-2020)
• Table 108. Africa Aerosol Delivery Devices, by Application USD Million (2015-2020)
• Table 109. Africa Aerosol Delivery Devices, by Distribution Channel USD Million (2015-2020)
• Table 110. Africa Aerosol Delivery Devices, by Nebulizer USD Million (2015-2020)
• Table 111. North America Aerosol Delivery Devices, by Country USD Million (2015-2020)
• Table 112. North America Aerosol Delivery Devices, by Type USD Million (2015-2020)
• Table 113. North America Aerosol Delivery Devices, by Application USD Million (2015-2020)
• Table 114. North America Aerosol Delivery Devices, by Distribution Channel USD Million (2015-2020)
• Table 115. North America Aerosol Delivery Devices, by Nebulizer USD Million (2015-2020)
• Table 116. United States Aerosol Delivery Devices, by Type USD Million (2015-2020)
• Table 117. United States Aerosol Delivery Devices, by Application USD Million (2015-2020)
• Table 118. United States Aerosol Delivery Devices, by Distribution Channel USD Million (2015-2020)
• Table 119. United States Aerosol Delivery Devices, by Nebulizer USD Million (2015-2020)
• Table 120. Canada Aerosol Delivery Devices, by Type USD Million (2015-2020)
• Table 121. Canada Aerosol Delivery Devices, by Application USD Million (2015-2020)
• Table 122. Canada Aerosol Delivery Devices, by Distribution Channel USD Million (2015-2020)
• Table 123. Canada Aerosol Delivery Devices, by Nebulizer USD Million (2015-2020)
• Table 124. Mexico Aerosol Delivery Devices, by Type USD Million (2015-2020)
• Table 125. Mexico Aerosol Delivery Devices, by Application USD Million (2015-2020)
• Table 126. Mexico Aerosol Delivery Devices, by Distribution Channel USD Million (2015-2020)
• Table 127. Mexico Aerosol Delivery Devices, by Nebulizer USD Million (2015-2020)
• Table 128. Aerosol Delivery Devices Sales: by Type(K Units)
• Table 129. Aerosol Delivery Devices Sales Small-Volume Nebulize , by Region K Units (2015-2020)
• Table 130. Aerosol Delivery Devices Sales Pressurized Metered-Dose Inhaler , by Region K Units (2015-2020)
• Table 131. Aerosol Delivery Devices Sales Dry-Powder Inhaler , by Region K Units (2015-2020)
• Table 132. Aerosol Delivery Devices Sales: by Application(K Units)
• Table 133. Aerosol Delivery Devices Sales Asthma , by Region K Units (2015-2020)
• Table 134. Aerosol Delivery Devices Sales Chronic Obstructive Pulmonary Disease (COPD) , by Region K Units (2015-2020)
• Table 135. Aerosol Delivery Devices Sales Cystic Fibrosis , by Region K Units (2015-2020)
• Table 136. Aerosol Delivery Devices Sales Non-Respiratory Diseases , by Region K Units (2015-2020)
• Table 137. Aerosol Delivery Devices Sales: by Distribution Channel(K Units)
• Table 138. Aerosol Delivery Devices Sales Retail Pharmacies , by Region K Units (2015-2020)
• Table 139. Aerosol Delivery Devices Sales Hospital Pharmacies , by Region K Units (2015-2020)
• Table 140. Aerosol Delivery Devices Sales E-commerce , by Region K Units (2015-2020)
• Table 141. Aerosol Delivery Devices Sales: by Nebulizer(K Units)
• Table 142. Aerosol Delivery Devices Sales Pneumatic Compressor Nebulizer , by Region K Units (2015-2020)
• Table 143. Aerosol Delivery Devices Sales Ultrasonic Nebulizer , by Region K Units (2015-2020)
• Table 144. Aerosol Delivery Devices Sales Vibrating Mesh/Horn Nebulizer , by Region K Units (2015-2020)
• Table 145. Aerosol Delivery Devices Sales Microprocessor-Controlled Breath-Actuated Nebulizer , by Region K Units (2015-2020)
• Table 146. South America Aerosol Delivery Devices Sales, by Country K Units (2015-2020)
• Table 147. South America Aerosol Delivery Devices Sales, by Type K Units (2015-2020)
• Table 148. South America Aerosol Delivery Devices Sales, by Application K Units (2015-2020)
• Table 149. South America Aerosol Delivery Devices Sales, by Distribution Channel K Units (2015-2020)
• Table 150. South America Aerosol Delivery Devices Sales, by Nebulizer K Units (2015-2020)
• Table 151. Brazil Aerosol Delivery Devices Sales, by Type K Units (2015-2020)
• Table 152. Brazil Aerosol Delivery Devices Sales, by Application K Units (2015-2020)
• Table 153. Brazil Aerosol Delivery Devices Sales, by Distribution Channel K Units (2015-2020)
• Table 154. Brazil Aerosol Delivery Devices Sales, by Nebulizer K Units (2015-2020)
• Table 155. Argentina Aerosol Delivery Devices Sales, by Type K Units (2015-2020)
• Table 156. Argentina Aerosol Delivery Devices Sales, by Application K Units (2015-2020)
• Table 157. Argentina Aerosol Delivery Devices Sales, by Distribution Channel K Units (2015-2020)
• Table 158. Argentina Aerosol Delivery Devices Sales, by Nebulizer K Units (2015-2020)
• Table 159. Rest of South America Aerosol Delivery Devices Sales, by Type K Units (2015-2020)
• Table 160. Rest of South America Aerosol Delivery Devices Sales, by Application K Units (2015-2020)
• Table 161. Rest of South America Aerosol Delivery Devices Sales, by Distribution Channel K Units (2015-2020)
• Table 162. Rest of South America Aerosol Delivery Devices Sales, by Nebulizer K Units (2015-2020)
• Table 163. Asia Pacific Aerosol Delivery Devices Sales, by Country K Units (2015-2020)
• Table 164. Asia Pacific Aerosol Delivery Devices Sales, by Type K Units (2015-2020)
• Table 165. Asia Pacific Aerosol Delivery Devices Sales, by Application K Units (2015-2020)
• Table 166. Asia Pacific Aerosol Delivery Devices Sales, by Distribution Channel K Units (2015-2020)
• Table 167. Asia Pacific Aerosol Delivery Devices Sales, by Nebulizer K Units (2015-2020)
• Table 168. China Aerosol Delivery Devices Sales, by Type K Units (2015-2020)
• Table 169. China Aerosol Delivery Devices Sales, by Application K Units (2015-2020)
• Table 170. China Aerosol Delivery Devices Sales, by Distribution Channel K Units (2015-2020)
• Table 171. China Aerosol Delivery Devices Sales, by Nebulizer K Units (2015-2020)
• Table 172. Japan Aerosol Delivery Devices Sales, by Type K Units (2015-2020)
• Table 173. Japan Aerosol Delivery Devices Sales, by Application K Units (2015-2020)
• Table 174. Japan Aerosol Delivery Devices Sales, by Distribution Channel K Units (2015-2020)
• Table 175. Japan Aerosol Delivery Devices Sales, by Nebulizer K Units (2015-2020)
• Table 176. India Aerosol Delivery Devices Sales, by Type K Units (2015-2020)
• Table 177. India Aerosol Delivery Devices Sales, by Application K Units (2015-2020)
• Table 178. India Aerosol Delivery Devices Sales, by Distribution Channel K Units (2015-2020)
• Table 179. India Aerosol Delivery Devices Sales, by Nebulizer K Units (2015-2020)
• Table 180. South Korea Aerosol Delivery Devices Sales, by Type K Units (2015-2020)
• Table 181. South Korea Aerosol Delivery Devices Sales, by Application K Units (2015-2020)
• Table 182. South Korea Aerosol Delivery Devices Sales, by Distribution Channel K Units (2015-2020)
• Table 183. South Korea Aerosol Delivery Devices Sales, by Nebulizer K Units (2015-2020)
• Table 184. Taiwan Aerosol Delivery Devices Sales, by Type K Units (2015-2020)
• Table 185. Taiwan Aerosol Delivery Devices Sales, by Application K Units (2015-2020)
• Table 186. Taiwan Aerosol Delivery Devices Sales, by Distribution Channel K Units (2015-2020)
• Table 187. Taiwan Aerosol Delivery Devices Sales, by Nebulizer K Units (2015-2020)
• Table 188. Australia Aerosol Delivery Devices Sales, by Type K Units (2015-2020)
• Table 189. Australia Aerosol Delivery Devices Sales, by Application K Units (2015-2020)
• Table 190. Australia Aerosol Delivery Devices Sales, by Distribution Channel K Units (2015-2020)
• Table 191. Australia Aerosol Delivery Devices Sales, by Nebulizer K Units (2015-2020)
• Table 192. Rest of Asia-Pacific Aerosol Delivery Devices Sales, by Type K Units (2015-2020)
• Table 193. Rest of Asia-Pacific Aerosol Delivery Devices Sales, by Application K Units (2015-2020)
• Table 194. Rest of Asia-Pacific Aerosol Delivery Devices Sales, by Distribution Channel K Units (2015-2020)
• Table 195. Rest of Asia-Pacific Aerosol Delivery Devices Sales, by Nebulizer K Units (2015-2020)
• Table 196. Europe Aerosol Delivery Devices Sales, by Country K Units (2015-2020)
• Table 197. Europe Aerosol Delivery Devices Sales, by Type K Units (2015-2020)
• Table 198. Europe Aerosol Delivery Devices Sales, by Application K Units (2015-2020)
• Table 199. Europe Aerosol Delivery Devices Sales, by Distribution Channel K Units (2015-2020)
• Table 200. Europe Aerosol Delivery Devices Sales, by Nebulizer K Units (2015-2020)
• Table 201. Germany Aerosol Delivery Devices Sales, by Type K Units (2015-2020)
• Table 202. Germany Aerosol Delivery Devices Sales, by Application K Units (2015-2020)
• Table 203. Germany Aerosol Delivery Devices Sales, by Distribution Channel K Units (2015-2020)
• Table 204. Germany Aerosol Delivery Devices Sales, by Nebulizer K Units (2015-2020)
• Table 205. France Aerosol Delivery Devices Sales, by Type K Units (2015-2020)
• Table 206. France Aerosol Delivery Devices Sales, by Application K Units (2015-2020)
• Table 207. France Aerosol Delivery Devices Sales, by Distribution Channel K Units (2015-2020)
• Table 208. France Aerosol Delivery Devices Sales, by Nebulizer K Units (2015-2020)
• Table 209. Italy Aerosol Delivery Devices Sales, by Type K Units (2015-2020)
• Table 210. Italy Aerosol Delivery Devices Sales, by Application K Units (2015-2020)
• Table 211. Italy Aerosol Delivery Devices Sales, by Distribution Channel K Units (2015-2020)
• Table 212. Italy Aerosol Delivery Devices Sales, by Nebulizer K Units (2015-2020)
• Table 213. United Kingdom Aerosol Delivery Devices Sales, by Type K Units (2015-2020)
• Table 214. United Kingdom Aerosol Delivery Devices Sales, by Application K Units (2015-2020)
• Table 215. United Kingdom Aerosol Delivery Devices Sales, by Distribution Channel K Units (2015-2020)
• Table 216. United Kingdom Aerosol Delivery Devices Sales, by Nebulizer K Units (2015-2020)
• Table 217. Netherlands Aerosol Delivery Devices Sales, by Type K Units (2015-2020)
• Table 218. Netherlands Aerosol Delivery Devices Sales, by Application K Units (2015-2020)
• Table 219. Netherlands Aerosol Delivery Devices Sales, by Distribution Channel K Units (2015-2020)
• Table 220. Netherlands Aerosol Delivery Devices Sales, by Nebulizer K Units (2015-2020)
• Table 221. Rest of Europe Aerosol Delivery Devices Sales, by Type K Units (2015-2020)
• Table 222. Rest of Europe Aerosol Delivery Devices Sales, by Application K Units (2015-2020)
• Table 223. Rest of Europe Aerosol Delivery Devices Sales, by Distribution Channel K Units (2015-2020)
• Table 224. Rest of Europe Aerosol Delivery Devices Sales, by Nebulizer K Units (2015-2020)
• Table 225. MEA Aerosol Delivery Devices Sales, by Country K Units (2015-2020)
• Table 226. MEA Aerosol Delivery Devices Sales, by Type K Units (2015-2020)
• Table 227. MEA Aerosol Delivery Devices Sales, by Application K Units (2015-2020)
• Table 228. MEA Aerosol Delivery Devices Sales, by Distribution Channel K Units (2015-2020)
• Table 229. MEA Aerosol Delivery Devices Sales, by Nebulizer K Units (2015-2020)
• Table 230. Middle East Aerosol Delivery Devices Sales, by Type K Units (2015-2020)
• Table 231. Middle East Aerosol Delivery Devices Sales, by Application K Units (2015-2020)
• Table 232. Middle East Aerosol Delivery Devices Sales, by Distribution Channel K Units (2015-2020)
• Table 233. Middle East Aerosol Delivery Devices Sales, by Nebulizer K Units (2015-2020)
• Table 234. Africa Aerosol Delivery Devices Sales, by Type K Units (2015-2020)
• Table 235. Africa Aerosol Delivery Devices Sales, by Application K Units (2015-2020)
• Table 236. Africa Aerosol Delivery Devices Sales, by Distribution Channel K Units (2015-2020)
• Table 237. Africa Aerosol Delivery Devices Sales, by Nebulizer K Units (2015-2020)
• Table 238. North America Aerosol Delivery Devices Sales, by Country K Units (2015-2020)
• Table 239. North America Aerosol Delivery Devices Sales, by Type K Units (2015-2020)
• Table 240. North America Aerosol Delivery Devices Sales, by Application K Units (2015-2020)
• Table 241. North America Aerosol Delivery Devices Sales, by Distribution Channel K Units (2015-2020)
• Table 242. North America Aerosol Delivery Devices Sales, by Nebulizer K Units (2015-2020)
• Table 243. United States Aerosol Delivery Devices Sales, by Type K Units (2015-2020)
• Table 244. United States Aerosol Delivery Devices Sales, by Application K Units (2015-2020)
• Table 245. United States Aerosol Delivery Devices Sales, by Distribution Channel K Units (2015-2020)
• Table 246. United States Aerosol Delivery Devices Sales, by Nebulizer K Units (2015-2020)
• Table 247. Canada Aerosol Delivery Devices Sales, by Type K Units (2015-2020)
• Table 248. Canada Aerosol Delivery Devices Sales, by Application K Units (2015-2020)
• Table 249. Canada Aerosol Delivery Devices Sales, by Distribution Channel K Units (2015-2020)
• Table 250. Canada Aerosol Delivery Devices Sales, by Nebulizer K Units (2015-2020)
• Table 251. Mexico Aerosol Delivery Devices Sales, by Type K Units (2015-2020)
• Table 252. Mexico Aerosol Delivery Devices Sales, by Application K Units (2015-2020)
• Table 253. Mexico Aerosol Delivery Devices Sales, by Distribution Channel K Units (2015-2020)
• Table 254. Mexico Aerosol Delivery Devices Sales, by Nebulizer K Units (2015-2020)
• Table 255. Aerosol Delivery Devices: by Type(USD/Units)
• Table 256. Company Basic Information, Sales Area and Its Competitors
• Table 257. Company Basic Information, Sales Area and Its Competitors
• Table 258. Company Basic Information, Sales Area and Its Competitors
• Table 259. Company Basic Information, Sales Area and Its Competitors
• Table 260. Company Basic Information, Sales Area and Its Competitors
• Table 261. Company Basic Information, Sales Area and Its Competitors
• Table 262. Company Basic Information, Sales Area and Its Competitors
• Table 263. Company Basic Information, Sales Area and Its Competitors
• Table 264. Company Basic Information, Sales Area and Its Competitors
• Table 265. Company Basic Information, Sales Area and Its Competitors
• Table 266. Aerosol Delivery Devices: by Type(USD Million)
• Table 267. Aerosol Delivery Devices Small-Volume Nebulize , by Region USD Million (2021-2026)
• Table 268. Aerosol Delivery Devices Pressurized Metered-Dose Inhaler , by Region USD Million (2021-2026)
• Table 269. Aerosol Delivery Devices Dry-Powder Inhaler , by Region USD Million (2021-2026)
• Table 270. Aerosol Delivery Devices: by Application(USD Million)
• Table 271. Aerosol Delivery Devices Asthma , by Region USD Million (2021-2026)
• Table 272. Aerosol Delivery Devices Chronic Obstructive Pulmonary Disease (COPD) , by Region USD Million (2021-2026)
• Table 273. Aerosol Delivery Devices Cystic Fibrosis , by Region USD Million (2021-2026)
• Table 274. Aerosol Delivery Devices Non-Respiratory Diseases , by Region USD Million (2021-2026)
• Table 275. Aerosol Delivery Devices: by Distribution Channel(USD Million)
• Table 276. Aerosol Delivery Devices Retail Pharmacies , by Region USD Million (2021-2026)
• Table 277. Aerosol Delivery Devices Hospital Pharmacies , by Region USD Million (2021-2026)
• Table 278. Aerosol Delivery Devices E-commerce , by Region USD Million (2021-2026)
• Table 279. Aerosol Delivery Devices: by Nebulizer(USD Million)
• Table 280. Aerosol Delivery Devices Pneumatic Compressor Nebulizer , by Region USD Million (2021-2026)
• Table 281. Aerosol Delivery Devices Ultrasonic Nebulizer , by Region USD Million (2021-2026)
• Table 282. Aerosol Delivery Devices Vibrating Mesh/Horn Nebulizer , by Region USD Million (2021-2026)
• Table 283. Aerosol Delivery Devices Microprocessor-Controlled Breath-Actuated Nebulizer , by Region USD Million (2021-2026)
• Table 284. South America Aerosol Delivery Devices, by Country USD Million (2021-2026)
• Table 285. South America Aerosol Delivery Devices, by Type USD Million (2021-2026)
• Table 286. South America Aerosol Delivery Devices, by Application USD Million (2021-2026)
• Table 287. South America Aerosol Delivery Devices, by Distribution Channel USD Million (2021-2026)
• Table 288. South America Aerosol Delivery Devices, by Nebulizer USD Million (2021-2026)
• Table 289. Brazil Aerosol Delivery Devices, by Type USD Million (2021-2026)
• Table 290. Brazil Aerosol Delivery Devices, by Application USD Million (2021-2026)
• Table 291. Brazil Aerosol Delivery Devices, by Distribution Channel USD Million (2021-2026)
• Table 292. Brazil Aerosol Delivery Devices, by Nebulizer USD Million (2021-2026)
• Table 293. Argentina Aerosol Delivery Devices, by Type USD Million (2021-2026)
• Table 294. Argentina Aerosol Delivery Devices, by Application USD Million (2021-2026)
• Table 295. Argentina Aerosol Delivery Devices, by Distribution Channel USD Million (2021-2026)
• Table 296. Argentina Aerosol Delivery Devices, by Nebulizer USD Million (2021-2026)
• Table 297. Rest of South America Aerosol Delivery Devices, by Type USD Million (2021-2026)
• Table 298. Rest of South America Aerosol Delivery Devices, by Application USD Million (2021-2026)
• Table 299. Rest of South America Aerosol Delivery Devices, by Distribution Channel USD Million (2021-2026)
• Table 300. Rest of South America Aerosol Delivery Devices, by Nebulizer USD Million (2021-2026)
• Table 301. Asia Pacific Aerosol Delivery Devices, by Country USD Million (2021-2026)
• Table 302. Asia Pacific Aerosol Delivery Devices, by Type USD Million (2021-2026)
• Table 303. Asia Pacific Aerosol Delivery Devices, by Application USD Million (2021-2026)
• Table 304. Asia Pacific Aerosol Delivery Devices, by Distribution Channel USD Million (2021-2026)
• Table 305. Asia Pacific Aerosol Delivery Devices, by Nebulizer USD Million (2021-2026)
• Table 306. China Aerosol Delivery Devices, by Type USD Million (2021-2026)
• Table 307. China Aerosol Delivery Devices, by Application USD Million (2021-2026)
• Table 308. China Aerosol Delivery Devices, by Distribution Channel USD Million (2021-2026)
• Table 309. China Aerosol Delivery Devices, by Nebulizer USD Million (2021-2026)
• Table 310. Japan Aerosol Delivery Devices, by Type USD Million (2021-2026)
• Table 311. Japan Aerosol Delivery Devices, by Application USD Million (2021-2026)
• Table 312. Japan Aerosol Delivery Devices, by Distribution Channel USD Million (2021-2026)
• Table 313. Japan Aerosol Delivery Devices, by Nebulizer USD Million (2021-2026)
• Table 314. India Aerosol Delivery Devices, by Type USD Million (2021-2026)
• Table 315. India Aerosol Delivery Devices, by Application USD Million (2021-2026)
• Table 316. India Aerosol Delivery Devices, by Distribution Channel USD Million (2021-2026)
• Table 317. India Aerosol Delivery Devices, by Nebulizer USD Million (2021-2026)
• Table 318. South Korea Aerosol Delivery Devices, by Type USD Million (2021-2026)
• Table 319. South Korea Aerosol Delivery Devices, by Application USD Million (2021-2026)
• Table 320. South Korea Aerosol Delivery Devices, by Distribution Channel USD Million (2021-2026)
• Table 321. South Korea Aerosol Delivery Devices, by Nebulizer USD Million (2021-2026)
• Table 322. Taiwan Aerosol Delivery Devices, by Type USD Million (2021-2026)
• Table 323. Taiwan Aerosol Delivery Devices, by Application USD Million (2021-2026)
• Table 324. Taiwan Aerosol Delivery Devices, by Distribution Channel USD Million (2021-2026)
• Table 325. Taiwan Aerosol Delivery Devices, by Nebulizer USD Million (2021-2026)
• Table 326. Australia Aerosol Delivery Devices, by Type USD Million (2021-2026)
• Table 327. Australia Aerosol Delivery Devices, by Application USD Million (2021-2026)
• Table 328. Australia Aerosol Delivery Devices, by Distribution Channel USD Million (2021-2026)
• Table 329. Australia Aerosol Delivery Devices, by Nebulizer USD Million (2021-2026)
• Table 330. Rest of Asia-Pacific Aerosol Delivery Devices, by Type USD Million (2021-2026)
• Table 331. Rest of Asia-Pacific Aerosol Delivery Devices, by Application USD Million (2021-2026)
• Table 332. Rest of Asia-Pacific Aerosol Delivery Devices, by Distribution Channel USD Million (2021-2026)
• Table 333. Rest of Asia-Pacific Aerosol Delivery Devices, by Nebulizer USD Million (2021-2026)
• Table 334. Europe Aerosol Delivery Devices, by Country USD Million (2021-2026)
• Table 335. Europe Aerosol Delivery Devices, by Type USD Million (2021-2026)
• Table 336. Europe Aerosol Delivery Devices, by Application USD Million (2021-2026)
• Table 337. Europe Aerosol Delivery Devices, by Distribution Channel USD Million (2021-2026)
• Table 338. Europe Aerosol Delivery Devices, by Nebulizer USD Million (2021-2026)
• Table 339. Germany Aerosol Delivery Devices, by Type USD Million (2021-2026)
• Table 340. Germany Aerosol Delivery Devices, by Application USD Million (2021-2026)
• Table 341. Germany Aerosol Delivery Devices, by Distribution Channel USD Million (2021-2026)
• Table 342. Germany Aerosol Delivery Devices, by Nebulizer USD Million (2021-2026)
• Table 343. France Aerosol Delivery Devices, by Type USD Million (2021-2026)
• Table 344. France Aerosol Delivery Devices, by Application USD Million (2021-2026)
• Table 345. France Aerosol Delivery Devices, by Distribution Channel USD Million (2021-2026)
• Table 346. France Aerosol Delivery Devices, by Nebulizer USD Million (2021-2026)
• Table 347. Italy Aerosol Delivery Devices, by Type USD Million (2021-2026)
• Table 348. Italy Aerosol Delivery Devices, by Application USD Million (2021-2026)
• Table 349. Italy Aerosol Delivery Devices, by Distribution Channel USD Million (2021-2026)
• Table 350. Italy Aerosol Delivery Devices, by Nebulizer USD Million (2021-2026)
• Table 351. United Kingdom Aerosol Delivery Devices, by Type USD Million (2021-2026)
• Table 352. United Kingdom Aerosol Delivery Devices, by Application USD Million (2021-2026)
• Table 353. United Kingdom Aerosol Delivery Devices, by Distribution Channel USD Million (2021-2026)
• Table 354. United Kingdom Aerosol Delivery Devices, by Nebulizer USD Million (2021-2026)
• Table 355. Netherlands Aerosol Delivery Devices, by Type USD Million (2021-2026)
• Table 356. Netherlands Aerosol Delivery Devices, by Application USD Million (2021-2026)
• Table 357. Netherlands Aerosol Delivery Devices, by Distribution Channel USD Million (2021-2026)
• Table 358. Netherlands Aerosol Delivery Devices, by Nebulizer USD Million (2021-2026)
• Table 359. Rest of Europe Aerosol Delivery Devices, by Type USD Million (2021-2026)
• Table 360. Rest of Europe Aerosol Delivery Devices, by Application USD Million (2021-2026)
• Table 361. Rest of Europe Aerosol Delivery Devices, by Distribution Channel USD Million (2021-2026)
• Table 362. Rest of Europe Aerosol Delivery Devices, by Nebulizer USD Million (2021-2026)
• Table 363. MEA Aerosol Delivery Devices, by Country USD Million (2021-2026)
• Table 364. MEA Aerosol Delivery Devices, by Type USD Million (2021-2026)
• Table 365. MEA Aerosol Delivery Devices, by Application USD Million (2021-2026)
• Table 366. MEA Aerosol Delivery Devices, by Distribution Channel USD Million (2021-2026)
• Table 367. MEA Aerosol Delivery Devices, by Nebulizer USD Million (2021-2026)
• Table 368. Middle East Aerosol Delivery Devices, by Type USD Million (2021-2026)
• Table 369. Middle East Aerosol Delivery Devices, by Application USD Million (2021-2026)
• Table 370. Middle East Aerosol Delivery Devices, by Distribution Channel USD Million (2021-2026)
• Table 371. Middle East Aerosol Delivery Devices, by Nebulizer USD Million (2021-2026)
• Table 372. Africa Aerosol Delivery Devices, by Type USD Million (2021-2026)
• Table 373. Africa Aerosol Delivery Devices, by Application USD Million (2021-2026)
• Table 374. Africa Aerosol Delivery Devices, by Distribution Channel USD Million (2021-2026)
• Table 375. Africa Aerosol Delivery Devices, by Nebulizer USD Million (2021-2026)
• Table 376. North America Aerosol Delivery Devices, by Country USD Million (2021-2026)
• Table 377. North America Aerosol Delivery Devices, by Type USD Million (2021-2026)
• Table 378. North America Aerosol Delivery Devices, by Application USD Million (2021-2026)
• Table 379. North America Aerosol Delivery Devices, by Distribution Channel USD Million (2021-2026)
• Table 380. North America Aerosol Delivery Devices, by Nebulizer USD Million (2021-2026)
• Table 381. United States Aerosol Delivery Devices, by Type USD Million (2021-2026)
• Table 382. United States Aerosol Delivery Devices, by Application USD Million (2021-2026)
• Table 383. United States Aerosol Delivery Devices, by Distribution Channel USD Million (2021-2026)
• Table 384. United States Aerosol Delivery Devices, by Nebulizer USD Million (2021-2026)
• Table 385. Canada Aerosol Delivery Devices, by Type USD Million (2021-2026)
• Table 386. Canada Aerosol Delivery Devices, by Application USD Million (2021-2026)
• Table 387. Canada Aerosol Delivery Devices, by Distribution Channel USD Million (2021-2026)
• Table 388. Canada Aerosol Delivery Devices, by Nebulizer USD Million (2021-2026)
• Table 389. Mexico Aerosol Delivery Devices, by Type USD Million (2021-2026)
• Table 390. Mexico Aerosol Delivery Devices, by Application USD Million (2021-2026)
• Table 391. Mexico Aerosol Delivery Devices, by Distribution Channel USD Million (2021-2026)
• Table 392. Mexico Aerosol Delivery Devices, by Nebulizer USD Million (2021-2026)
• Table 393. Aerosol Delivery Devices Sales: by Type(K Units)
• Table 394. Aerosol Delivery Devices Sales Small-Volume Nebulize , by Region K Units (2021-2026)
• Table 395. Aerosol Delivery Devices Sales Pressurized Metered-Dose Inhaler , by Region K Units (2021-2026)
• Table 396. Aerosol Delivery Devices Sales Dry-Powder Inhaler , by Region K Units (2021-2026)
• Table 397. Aerosol Delivery Devices Sales: by Application(K Units)
• Table 398. Aerosol Delivery Devices Sales Asthma , by Region K Units (2021-2026)
• Table 399. Aerosol Delivery Devices Sales Chronic Obstructive Pulmonary Disease (COPD) , by Region K Units (2021-2026)
• Table 400. Aerosol Delivery Devices Sales Cystic Fibrosis , by Region K Units (2021-2026)
• Table 401. Aerosol Delivery Devices Sales Non-Respiratory Diseases , by Region K Units (2021-2026)
• Table 402. Aerosol Delivery Devices Sales: by Distribution Channel(K Units)
• Table 403. Aerosol Delivery Devices Sales Retail Pharmacies , by Region K Units (2021-2026)
• Table 404. Aerosol Delivery Devices Sales Hospital Pharmacies , by Region K Units (2021-2026)
• Table 405. Aerosol Delivery Devices Sales E-commerce , by Region K Units (2021-2026)
• Table 406. Aerosol Delivery Devices Sales: by Nebulizer(K Units)
• Table 407. Aerosol Delivery Devices Sales Pneumatic Compressor Nebulizer , by Region K Units (2021-2026)
• Table 408. Aerosol Delivery Devices Sales Ultrasonic Nebulizer , by Region K Units (2021-2026)
• Table 409. Aerosol Delivery Devices Sales Vibrating Mesh/Horn Nebulizer , by Region K Units (2021-2026)
• Table 410. Aerosol Delivery Devices Sales Microprocessor-Controlled Breath-Actuated Nebulizer , by Region K Units (2021-2026)
• Table 411. South America Aerosol Delivery Devices Sales, by Country K Units (2021-2026)
• Table 412. South America Aerosol Delivery Devices Sales, by Type K Units (2021-2026)
• Table 413. South America Aerosol Delivery Devices Sales, by Application K Units (2021-2026)
• Table 414. South America Aerosol Delivery Devices Sales, by Distribution Channel K Units (2021-2026)
• Table 415. South America Aerosol Delivery Devices Sales, by Nebulizer K Units (2021-2026)
• Table 416. Brazil Aerosol Delivery Devices Sales, by Type K Units (2021-2026)
• Table 417. Brazil Aerosol Delivery Devices Sales, by Application K Units (2021-2026)
• Table 418. Brazil Aerosol Delivery Devices Sales, by Distribution Channel K Units (2021-2026)
• Table 419. Brazil Aerosol Delivery Devices Sales, by Nebulizer K Units (2021-2026)
• Table 420. Argentina Aerosol Delivery Devices Sales, by Type K Units (2021-2026)
• Table 421. Argentina Aerosol Delivery Devices Sales, by Application K Units (2021-2026)
• Table 422. Argentina Aerosol Delivery Devices Sales, by Distribution Channel K Units (2021-2026)
• Table 423. Argentina Aerosol Delivery Devices Sales, by Nebulizer K Units (2021-2026)
• Table 424. Rest of South America Aerosol Delivery Devices Sales, by Type K Units (2021-2026)
• Table 425. Rest of South America Aerosol Delivery Devices Sales, by Application K Units (2021-2026)
• Table 426. Rest of South America Aerosol Delivery Devices Sales, by Distribution Channel K Units (2021-2026)
• Table 427. Rest of South America Aerosol Delivery Devices Sales, by Nebulizer K Units (2021-2026)
• Table 428. Asia Pacific Aerosol Delivery Devices Sales, by Country K Units (2021-2026)
• Table 429. Asia Pacific Aerosol Delivery Devices Sales, by Type K Units (2021-2026)
• Table 430. Asia Pacific Aerosol Delivery Devices Sales, by Application K Units (2021-2026)
• Table 431. Asia Pacific Aerosol Delivery Devices Sales, by Distribution Channel K Units (2021-2026)
• Table 432. Asia Pacific Aerosol Delivery Devices Sales, by Nebulizer K Units (2021-2026)
• Table 433. China Aerosol Delivery Devices Sales, by Type K Units (2021-2026)
• Table 434. China Aerosol Delivery Devices Sales, by Application K Units (2021-2026)
• Table 435. China Aerosol Delivery Devices Sales, by Distribution Channel K Units (2021-2026)
• Table 436. China Aerosol Delivery Devices Sales, by Nebulizer K Units (2021-2026)
• Table 437. Japan Aerosol Delivery Devices Sales, by Type K Units (2021-2026)
• Table 438. Japan Aerosol Delivery Devices Sales, by Application K Units (2021-2026)
• Table 439. Japan Aerosol Delivery Devices Sales, by Distribution Channel K Units (2021-2026)
• Table 440. Japan Aerosol Delivery Devices Sales, by Nebulizer K Units (2021-2026)
• Table 441. India Aerosol Delivery Devices Sales, by Type K Units (2021-2026)
• Table 442. India Aerosol Delivery Devices Sales, by Application K Units (2021-2026)
• Table 443. India Aerosol Delivery Devices Sales, by Distribution Channel K Units (2021-2026)
• Table 444. India Aerosol Delivery Devices Sales, by Nebulizer K Units (2021-2026)
• Table 445. South Korea Aerosol Delivery Devices Sales, by Type K Units (2021-2026)
• Table 446. South Korea Aerosol Delivery Devices Sales, by Application K Units (2021-2026)
• Table 447. South Korea Aerosol Delivery Devices Sales, by Distribution Channel K Units (2021-2026)
• Table 448. South Korea Aerosol Delivery Devices Sales, by Nebulizer K Units (2021-2026)
• Table 449. Taiwan Aerosol Delivery Devices Sales, by Type K Units (2021-2026)
• Table 450. Taiwan Aerosol Delivery Devices Sales, by Application K Units (2021-2026)
• Table 451. Taiwan Aerosol Delivery Devices Sales, by Distribution Channel K Units (2021-2026)
• Table 452. Taiwan Aerosol Delivery Devices Sales, by Nebulizer K Units (2021-2026)
• Table 453. Australia Aerosol Delivery Devices Sales, by Type K Units (2021-2026)
• Table 454. Australia Aerosol Delivery Devices Sales, by Application K Units (2021-2026)
• Table 455. Australia Aerosol Delivery Devices Sales, by Distribution Channel K Units (2021-2026)
• Table 456. Australia Aerosol Delivery Devices Sales, by Nebulizer K Units (2021-2026)
• Table 457. Rest of Asia-Pacific Aerosol Delivery Devices Sales, by Type K Units (2021-2026)
• Table 458. Rest of Asia-Pacific Aerosol Delivery Devices Sales, by Application K Units (2021-2026)
• Table 459. Rest of Asia-Pacific Aerosol Delivery Devices Sales, by Distribution Channel K Units (2021-2026)
• Table 460. Rest of Asia-Pacific Aerosol Delivery Devices Sales, by Nebulizer K Units (2021-2026)
• Table 461. Europe Aerosol Delivery Devices Sales, by Country K Units (2021-2026)
• Table 462. Europe Aerosol Delivery Devices Sales, by Type K Units (2021-2026)
• Table 463. Europe Aerosol Delivery Devices Sales, by Application K Units (2021-2026)
• Table 464. Europe Aerosol Delivery Devices Sales, by Distribution Channel K Units (2021-2026)
• Table 465. Europe Aerosol Delivery Devices Sales, by Nebulizer K Units (2021-2026)
• Table 466. Germany Aerosol Delivery Devices Sales, by Type K Units (2021-2026)
• Table 467. Germany Aerosol Delivery Devices Sales, by Application K Units (2021-2026)
• Table 468. Germany Aerosol Delivery Devices Sales, by Distribution Channel K Units (2021-2026)
• Table 469. Germany Aerosol Delivery Devices Sales, by Nebulizer K Units (2021-2026)
• Table 470. France Aerosol Delivery Devices Sales, by Type K Units (2021-2026)
• Table 471. France Aerosol Delivery Devices Sales, by Application K Units (2021-2026)
• Table 472. France Aerosol Delivery Devices Sales, by Distribution Channel K Units (2021-2026)
• Table 473. France Aerosol Delivery Devices Sales, by Nebulizer K Units (2021-2026)
• Table 474. Italy Aerosol Delivery Devices Sales, by Type K Units (2021-2026)
• Table 475. Italy Aerosol Delivery Devices Sales, by Application K Units (2021-2026)
• Table 476. Italy Aerosol Delivery Devices Sales, by Distribution Channel K Units (2021-2026)
• Table 477. Italy Aerosol Delivery Devices Sales, by Nebulizer K Units (2021-2026)
• Table 478. United Kingdom Aerosol Delivery Devices Sales, by Type K Units (2021-2026)
• Table 479. United Kingdom Aerosol Delivery Devices Sales, by Application K Units (2021-2026)
• Table 480. United Kingdom Aerosol Delivery Devices Sales, by Distribution Channel K Units (2021-2026)
• Table 481. United Kingdom Aerosol Delivery Devices Sales, by Nebulizer K Units (2021-2026)
• Table 482. Netherlands Aerosol Delivery Devices Sales, by Type K Units (2021-2026)
• Table 483. Netherlands Aerosol Delivery Devices Sales, by Application K Units (2021-2026)
• Table 484. Netherlands Aerosol Delivery Devices Sales, by Distribution Channel K Units (2021-2026)
• Table 485. Netherlands Aerosol Delivery Devices Sales, by Nebulizer K Units (2021-2026)
• Table 486. Rest of Europe Aerosol Delivery Devices Sales, by Type K Units (2021-2026)
• Table 487. Rest of Europe Aerosol Delivery Devices Sales, by Application K Units (2021-2026)
• Table 488. Rest of Europe Aerosol Delivery Devices Sales, by Distribution Channel K Units (2021-2026)
• Table 489. Rest of Europe Aerosol Delivery Devices Sales, by Nebulizer K Units (2021-2026)
• Table 490. MEA Aerosol Delivery Devices Sales, by Country K Units (2021-2026)
• Table 491. MEA Aerosol Delivery Devices Sales, by Type K Units (2021-2026)
• Table 492. MEA Aerosol Delivery Devices Sales, by Application K Units (2021-2026)
• Table 493. MEA Aerosol Delivery Devices Sales, by Distribution Channel K Units (2021-2026)
• Table 494. MEA Aerosol Delivery Devices Sales, by Nebulizer K Units (2021-2026)
• Table 495. Middle East Aerosol Delivery Devices Sales, by Type K Units (2021-2026)
• Table 496. Middle East Aerosol Delivery Devices Sales, by Application K Units (2021-2026)
• Table 497. Middle East Aerosol Delivery Devices Sales, by Distribution Channel K Units (2021-2026)
• Table 498. Middle East Aerosol Delivery Devices Sales, by Nebulizer K Units (2021-2026)
• Table 499. Africa Aerosol Delivery Devices Sales, by Type K Units (2021-2026)
• Table 500. Africa Aerosol Delivery Devices Sales, by Application K Units (2021-2026)
• Table 501. Africa Aerosol Delivery Devices Sales, by Distribution Channel K Units (2021-2026)
• Table 502. Africa Aerosol Delivery Devices Sales, by Nebulizer K Units (2021-2026)
• Table 503. North America Aerosol Delivery Devices Sales, by Country K Units (2021-2026)
• Table 504. North America Aerosol Delivery Devices Sales, by Type K Units (2021-2026)
• Table 505. North America Aerosol Delivery Devices Sales, by Application K Units (2021-2026)
• Table 506. North America Aerosol Delivery Devices Sales, by Distribution Channel K Units (2021-2026)
• Table 507. North America Aerosol Delivery Devices Sales, by Nebulizer K Units (2021-2026)
• Table 508. United States Aerosol Delivery Devices Sales, by Type K Units (2021-2026)
• Table 509. United States Aerosol Delivery Devices Sales, by Application K Units (2021-2026)
• Table 510. United States Aerosol Delivery Devices Sales, by Distribution Channel K Units (2021-2026)
• Table 511. United States Aerosol Delivery Devices Sales, by Nebulizer K Units (2021-2026)
• Table 512. Canada Aerosol Delivery Devices Sales, by Type K Units (2021-2026)
• Table 513. Canada Aerosol Delivery Devices Sales, by Application K Units (2021-2026)
• Table 514. Canada Aerosol Delivery Devices Sales, by Distribution Channel K Units (2021-2026)
• Table 515. Canada Aerosol Delivery Devices Sales, by Nebulizer K Units (2021-2026)
• Table 516. Mexico Aerosol Delivery Devices Sales, by Type K Units (2021-2026)
• Table 517. Mexico Aerosol Delivery Devices Sales, by Application K Units (2021-2026)
• Table 518. Mexico Aerosol Delivery Devices Sales, by Distribution Channel K Units (2021-2026)
• Table 519. Mexico Aerosol Delivery Devices Sales, by Nebulizer K Units (2021-2026)
• Table 520. Aerosol Delivery Devices: by Type(USD/Units)
• Table 521. Research Programs/Design for This Report
• Table 522. Key Data Information from Secondary Sources
• Table 523. Key Data Information from Primary Sources

• Figure 1. Porters Five Forces
• Figure 2. Supply/Value Chain
• Figure 3. PESTEL analysis
• Figure 4. Global Aerosol Delivery Devices: by Type USD Million (2015-2020)
• Figure 5. Global Aerosol Delivery Devices: by Application USD Million (2015-2020)
• Figure 6. Global Aerosol Delivery Devices: by Distribution Channel USD Million (2015-2020)
• Figure 7. Global Aerosol Delivery Devices: by Nebulizer USD Million (2015-2020)
• Figure 8. South America Aerosol Delivery Devices Share (%), by Country
• Figure 9. Asia Pacific Aerosol Delivery Devices Share (%), by Country
• Figure 10. Europe Aerosol Delivery Devices Share (%), by Country
• Figure 11. MEA Aerosol Delivery Devices Share (%), by Country
• Figure 12. North America Aerosol Delivery Devices Share (%), by Country
• Figure 13. Global Aerosol Delivery Devices: by Type K Units (2015-2020)
• Figure 14. Global Aerosol Delivery Devices: by Application K Units (2015-2020)
• Figure 15. Global Aerosol Delivery Devices: by Distribution Channel K Units (2015-2020)
• Figure 16. Global Aerosol Delivery Devices: by Nebulizer K Units (2015-2020)
• Figure 17. South America Aerosol Delivery Devices Share (%), by Country
• Figure 18. Asia Pacific Aerosol Delivery Devices Share (%), by Country
• Figure 19. Europe Aerosol Delivery Devices Share (%), by Country
• Figure 20. MEA Aerosol Delivery Devices Share (%), by Country
• Figure 21. North America Aerosol Delivery Devices Share (%), by Country
• Figure 22. Global Aerosol Delivery Devices: by Type USD/Units (2015-2020)
• Figure 23. Global Aerosol Delivery Devices share by Players 2020 (%)
• Figure 24. Global Aerosol Delivery Devices share by Players (Top 3) 2020(%)
• Figure 25. Global Aerosol Delivery Devices share by Players (Top 5) 2020(%)
• Figure 26. BCG Matrix for key Companies
• Figure 27. 3M Company (United States) Revenue, Net Income and Gross profit
• Figure 28. 3M Company (United States) Revenue: by Geography 2020
• Figure 29. Aerogen, Inc. (Ireland) Revenue, Net Income and Gross profit
• Figure 30. Aerogen, Inc. (Ireland) Revenue: by Geography 2020
• Figure 31. Glaxosmithkline Plc (GSK) (United Kingdom) Revenue, Net Income and Gross profit
• Figure 32. Glaxosmithkline Plc (GSK) (United Kingdom) Revenue: by Geography 2020
• Figure 33. Johnson & Johnson (Actelion Pharmaceuticals Ltd) (United States) Revenue, Net Income and Gross profit
• Figure 34. Johnson & Johnson (Actelion Pharmaceuticals Ltd) (United States) Revenue: by Geography 2020
• Figure 35. Philips (Koninklijke Philips N.V.) (Netherlands) Revenue, Net Income and Gross profit
• Figure 36. Philips (Koninklijke Philips N.V.) (Netherlands) Revenue: by Geography 2020
• Figure 37. Merck & Co., Inc. (United States) Revenue, Net Income and Gross profit
• Figure 38. Merck & Co., Inc. (United States) Revenue: by Geography 2020
• Figure 39. Metall Zug Group (Clement Clarke International Ltd) (Switzerland) Revenue, Net Income and Gross profit
• Figure 40. Metall Zug Group (Clement Clarke International Ltd) (Switzerland) Revenue: by Geography 2020
• Figure 41. Recipharm AB (Bespak) (Sweden) Revenue, Net Income and Gross profit
• Figure 42. Recipharm AB (Bespak) (Sweden) Revenue: by Geography 2020
• Figure 43. Teva Pharmaceutical Industries Limited (Israel) Revenue, Net Income and Gross profit
• Figure 44. Teva Pharmaceutical Industries Limited (Israel) Revenue: by Geography 2020
• Figure 45. Vectura Group PLC (United Kingdom) Revenue, Net Income and Gross profit
• Figure 46. Vectura Group PLC (United Kingdom) Revenue: by Geography 2020
• Figure 47. Global Aerosol Delivery Devices: by Type USD Million (2021-2026)
• Figure 48. Global Aerosol Delivery Devices: by Application USD Million (2021-2026)
• Figure 49. Global Aerosol Delivery Devices: by Distribution Channel USD Million (2021-2026)
• Figure 50. Global Aerosol Delivery Devices: by Nebulizer USD Million (2021-2026)
• Figure 51. South America Aerosol Delivery Devices Share (%), by Country
• Figure 52. Asia Pacific Aerosol Delivery Devices Share (%), by Country
• Figure 53. Europe Aerosol Delivery Devices Share (%), by Country
• Figure 54. MEA Aerosol Delivery Devices Share (%), by Country
• Figure 55. North America Aerosol Delivery Devices Share (%), by Country
• Figure 56. Global Aerosol Delivery Devices: by Type K Units (2021-2026)
• Figure 57. Global Aerosol Delivery Devices: by Application K Units (2021-2026)
• Figure 58. Global Aerosol Delivery Devices: by Distribution Channel K Units (2021-2026)
• Figure 59. Global Aerosol Delivery Devices: by Nebulizer K Units (2021-2026)
• Figure 60. South America Aerosol Delivery Devices Share (%), by Country
• Figure 61. Asia Pacific Aerosol Delivery Devices Share (%), by Country
• Figure 62. Europe Aerosol Delivery Devices Share (%), by Country
• Figure 63. MEA Aerosol Delivery Devices Share (%), by Country
• Figure 64. North America Aerosol Delivery Devices Share (%), by Country
• Figure 65. Global Aerosol Delivery Devices: by Type USD/Units (2021-2026)

• 3M Company (United States)
• Aerogen, Inc. (Ireland)
• Glaxosmithkline Plc (GSK) (United Kingdom)
• Johnson & Johnson (Actelion Pharmaceuticals Ltd) (United States)
• Philips (Koninklijke Philips N.V.) (Netherlands)
• Merck & Co., Inc. (United States)
• Metall Zug Group (Clement Clarke International Ltd) (Switzerland)
• Recipharm AB (Bespak) (Sweden)
• Teva Pharmaceutical Industries Limited (Israel)
• Vectura Group PLC (United Kingdom)